FDA updates labeling for ERTUGLIFLOZIN
Labeling changes approved for AUROBINDO PHARMA LTD. Active ingredient: ERTUGLIFLOZIN. Decision date: 12/03/2025
Labeling changes approved for AUROBINDO PHARMA LTD. Active ingredient: ERTUGLIFLOZIN. Decision date: 12/03/2025
There are no comments here yet...